Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
about
Myocardial Perfusion in Rheumatoid Arthritis Patients: Associations with Traditional Risk Factors and Novel Biomarkers.Exenatide can inhibit calcification of human VSMCs through the NF-kappaB/RANKL signaling pathway.Vascular calcification: Mechanisms of vascular smooth muscle cell calcificationOsteoprotegerin in Cardiometabolic Disorders.Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosis.The emerging role of interleukin-37 in cardiovascular diseases.Targeting local vascular and systemic consequences of inflammation on vascular and cardiac valve calcification.Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants.TRAIL attenuates RANKL-mediated osteoblastic signalling in vascular cell mono-culture and co-culture models.Tumour necrosis factor-alpha in uraemic serum promotes osteoblastic transition and calcification of vascular smooth muscle cells via extracellular signal-regulated kinases and activator protein 1/c-FOS-mediated induction of interleukin 6 expression.Differentiation of Vascular Stem Cells Contributes to Ectopic Calcification of Atherosclerotic Plaque.Expanded Haemodialysis Therapy of Chronic Haemodialysis Patients Prevents Calcification and Apoptosis of Vascular Smooth Muscle Cells in vitro.High cut-off dialysis in chronic haemodialysis patients reduces serum procalcific activity.In Vitro Dialysis of Cytokine-Rich Plasma With High and Medium Cut-Off Membranes Reduces Its Procalcific Activity.Role of smooth muscle cells in vascular calcification: implications in atherosclerosis and arterial stiffness.The Impact of Uremic Toxins on Vascular Smooth Muscle Cell Function.Role of osteoprotegerin in vascular disorders of the end-stage renal disease patients
P2860
Q33695937-E9A42709-6A84-4B79-93F0-B9FF76B821FDQ34560277-9E17C194-236A-4872-88D3-0E13BB8849EBQ35553833-9C5D41A2-3D97-4029-9874-A90FD892718DQ35640787-A6FB79C8-72F5-4ED7-B908-ECBB017504DAQ36324316-3019A7B4-8398-41B8-B7DA-828A0C53510FQ38678569-8D48B9A0-A527-4ABA-8970-FAE64212CD6FQ38703771-DC6BCE82-62B8-43AA-BA0C-99D7718612DBQ41513500-F17116BB-2548-4496-BCF6-FD74407007CFQ47128807-57EE0A46-25A4-4A30-AB32-C6BAAB7C6376Q47307137-0564EB1E-E878-45F5-9CAE-2B91FECC264EQ48247931-FA803B62-7BC1-42C7-8223-F7F470DC854DQ50149505-268621BF-5BCA-4BB7-869A-D71215399E52Q50234694-2AEEA9FB-C11E-438C-93FF-70E29CE4D19DQ50992671-FAB15B84-835B-4115-8ABC-5033F8DFF005Q51765103-38EC6230-BD02-4C9D-A299-39E0810F3BD5Q55515015-6A9952B7-E164-4073-BDAA-192C33477533Q57580529-EFD3A5D3-914A-47E4-AC90-5FA5D054BCDF
P2860
Increased calcification in osteoprotegerin-deficient smooth muscle cells: Dependence on receptor activator of NF-κB ligand and interleukin 6.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Increased calcification in ost ...... F-κB ligand and interleukin 6.
@en
type
label
Increased calcification in ost ...... F-κB ligand and interleukin 6.
@en
prefLabel
Increased calcification in ost ...... F-κB ligand and interleukin 6.
@en
P2093
P2860
P356
P1476
Increased calcification in ost ...... F-κB ligand and interleukin 6.
@en
P2093
Andrea Callegari
Jerry L Ricks
Marta Scatena
Matthew L Coons
Michael E Rosenfeld
P2860
P304
P356
10.1159/000358920
P577
2014-03-07T00:00:00Z